Listeria monocytogenes vaccine for previously treated malignant pleural mesothelioma ID1353
Discontinued
Reference number: GID-TA10320
The Department for Health and Social Care has asked NICE to carry out a Single Technology Appraisal of Listeria monocytogenes vaccine for previously treated malignant pleural mesothelioma.
For information, the company Aduro BioTech have advised that they are no longer pursuing a Marketing Authorisation Application from the European Medicines Agency for this indication at this time. Therefore, NICE has decided to suspend this appraisal from its current work programme.
As this appraisal has been referred NICE will continue to monitor any development and will update interested parties if the situation changes.